Esperion Therapeutics | ESPR - Action





Action Changement Date
AbbVie USD 5.05B 98M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amarin USD 183.58M 12.32M 2026-03
Amgen USD 6.19B 39M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Cipla INR 61.6B 5.18B 2025-09
CSL USD 6.47B 327M 2025-06
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
Geron USD 133.29M 16.65M 2026-03
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12